Lantern Pharma
LTRN | NASDAQ
$0.46
-$0.14 (-23.21%)
At close: Nov 10, 2026, 4:00 PM ET
-23.21%
(1D)No price chart data available for 1D timeframe.
Rating
22.8
+1.6 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #969/1027 (Top 94%)
Key Statistics
Market Data
Market Cap $6.92M
1D Range
0.45 0.67
52W Range
0.45 4.17
Valuation (TTM)
PE -0.28
PB -2.15
EV/EBITDA 0.02
Valuation (NTM)
Forward PE N/A
Forward PEG 0.15
Price Target $0.00
Cash Flow
FCF Yield -203.6%
SBC Adj. FCF Yield -216.5%
SBC Impact -6.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 0.9% |
-4.9%
FCF 3Y | 5Y 3.8% |
98.4%
Returns
ROA -216.8%
ROE -456.4%
ROIC -358.0%
Financial Health
Net Cash
$7.32M
Current Ratio 1.96
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensi...
Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Jun 11, 2020
Website www.lanternpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove LTRN